Project Grant R34DA064469
Award Date 5/15/26
Completion Date 4/30/29
Dollars Obligated $256K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, NY 10016, USA
Similar Awards
- Federal Grant Award Summary New York University School of Medicine received a $771,043 Project Grant award from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279), effective March 15, 2026, through December 31, 2030. The grant supports a hybrid Type II implementation-effectiveness trial of the LINKED (Leveraging Interpersonal Networks to Keep Engagement in PrEP & MOUD) intervention, a peer-driven social network program designed to increase...
- Federal Project Grant Award Summary Albert Einstein College of Medicine has received a $756,000 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded March 15, 2026, with completion scheduled for February 28, 2029. This award funds formative research and pilot testing of implementation strategies designed to improve Pre-Exposure Prophylaxis (PrEP) engagement among hospitalized people who use substances (PWUS). The...
- Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Public Health Foundation Enterprises, Inc. (doing business as Heluna Health) a Project Grant of $588,669 under the Drug Use and Addiction Research Programs (CFDA 93.279) for the period April 15, 2026 through January 31, 2031. The Street Prep intervention addresses the critical gap in HIV prevention services for people who use drugs and those experiencing homelessness in San Francisco, where new HIV diagnoses among people who...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Miami a $677,248 project grant on February 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and test the Comprehensive Telehealth Concierge (C-THR) Model. This peer-driven, telehealth-based intervention is designed to improve HIV Pre-Exposure Prophylaxis (PrEP) initiation and retention among individuals with histories of drug use who are exiting county...
- Federal Project Grant Award Summary New York University School of Medicine received a $2.09M project grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded July 1, 2025, with completion targeted for March 31, 2030. This research initiative characterizes complex Opioid Use Disorder (OUD) care trajectories and outcomes following acute service utilization through a population-based data linkage study. The project applies...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Icahn School of Medicine at Mount Sinai a $2,350,996 Project Grant on February 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct research examining the intersection of Human Immunodeficiency Virus (HIV) infection and opioid use disorder in the nucleus accumbens brain region. The award supports a four-year research initiative (through January 31, 2030) focused on mining...
- Federal Project Grant Award Summary New York University has been awarded $201,250 by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) for a two-year project period from June 1, 2025, through May 31, 2027. This Project Grant supports basic neuroscience research investigating the synaptic organization of cholinergic interneurons in the nucleus accumbens, a brain region critical to motivated behaviors and implicated in substance use...
- Federal Project Grant Award Summary The University of Miami's School of Medicine received a $793,508 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective March 1, 2026 through January 31, 2031. The award supports the STRIVES initiative, which develops and implements a status-neutral telehealth concierge (SN-THR) care model designed to deliver comprehensive HIV prevention, testing, and treatment services to...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of California, San Diego $2,312,059 under the Drug Use and Addiction Research Programs (CFDA 93.279) on August 1, 2025, for a five-year project period extending through April 30, 2030. The grant supports "Breaking Barriers: Innovating HIV Elimination with Social Network Strategies and Routine Substance Use Screening," a hybrid Type I clinical trial designed to identify and engage...
- Federal Project Grant Summary Rhode Island Hospital, a division of Lifespan Corporation, received a $859,962 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) awarded August 1, 2025, with a completion date of April 30, 2028. The grant supports the development and preliminary testing of a nurse-led, same-day HIV pre-exposure prophylaxis (PrEP) initiation intervention designed for incarcerated individuals, a population at...